Skip to content

uAI-CTA-HeadNeckVessels helped doctors find more brain aneurysms

In the maker's trial that China's CMDE reviewed, doctors using uAI-CTA-HeadNeckVessels detected 90.00% of intracranial aneurysms on CT angiograms, against 81.97% without it.

  • Not rated an organization

    Doctors read stored images in the maker's pre-market trial, and no patient's care depended on the software.

Depth runs from 1, a convenience or time saved, to 5, a life or a livelihood preserved.

Status
Intended benefit.
Evidence

found, the grade of this recordstudiedreportedclaimed

Two independent regulatory documents support the benefit.

Compared with

The same doctors reading the same CT angiograms without the software, with imaging experts' readings as the reference. Measured.

Without the system
81.97% lesion-level sensitivity
With it
90.00% lesion-level sensitivity
The system’s part
In a self-controlled, fully crossed design, doctors read every case with and without the software, so the gains are attributed to the software. The trial was the maker's own. The report says that the product uses deep learning.
Not yet checked
LimitsCosts and harmsLearns from dataLater outcome
Benefit type
Improved Task Accuracy
System
uAI-CTA-HeadNeckVessels (颅内动脉瘤CT造影图像辅助检测软件)
Made by
Shanghai United Imaging Intelligence Co., Ltd. (上海联影智能医疗科技有限公司)
Used by
Shanghai United Imaging Intelligence (retrospective reader trial on 484 cases at three institutions)
Where
Three trial institutions that the report does not name, for a registration in China
Stage
Tested in a laboratory
Date
, when the source was published
Kind
Aggregate result
Broad benefit
Identifying Objects, Actions, and Events
Collections
Scrutiny and findings
Last revised
1 November 2026

Sources

  1. Regulatory document, by authors with no tie to the system.

    Center for Medical Device Evaluation (CMDE), National Medical Products Administration, China. 医疗器械产品注册技术审评报告:颅内动脉瘤CT造影图像辅助检测软件 (technical review report for the registration of intracranial aneurysm detection-aid software for CT angiography images), acceptance no. CQZ2302223, applicant 上海联影智能医疗科技有限公司. 20 September 2024. Section 三、临床评价概述 (clinical evaluation).

    试验组与对照组动脉瘤检出敏感度(以病灶为单位)分别为 90.00%和 81.97%,敏感度之差及 95%CI 为 8.03%(4.38%, 11.67%),其下限大于 0。
    经综合评价,认为该产品上市带来的受益大于风险,综合剩余风险可接受。
  2. Regulatory document, by authors with no tie to the system.

    National Medical Products Administration (NMPA), China. CT Angiography Image-aided Detection Software for Intracranial Aneurysms Approved for Marketing. English-language notice, posted 19 February 2025. The notice names the maker as Shanghai United Imaging Healthcare Co., Ltd.

    This product adopts deep learning-based head and neck vessel segmentation technology and multi-scale aneurysm detection technology, which effectively improves the diagnostic accuracy and efficiency of intracranial aneurysms, and is of great significance in improving the survival rate of patients.

Details

AI system

Reported configuration

Release 2.2 (full version 2.2-0-0-72)

Workflow

The software segmented the head and neck vessels and marked suspected aneurysms with deep learning. Doctors read the CT angiograms with the software's marks as an aid.

Follow-up

Conditions for replication

Images are head and neck CT angiograms, and aneurysms are 3 mm or larger. Trained doctors read the images and do not base a clinical decision on the software alone.

Entry details

Sector

Healthcare.

Purpose

Shanghai United Imaging Intelligence built uAI-CTA-HeadNeckVessels to help trained doctors detect intracranial aneurysms of 3 mm or more on head and neck CT angiography images.

29 more questions not yet checked

model, provider, role, configuration, inputs and outputs, autonomy, human oversight, beneficiaries, reach, distribution and access, duration, every measurement question, every money question, ownership and control, dependencies, cross-border connections, geopolitical implications, replication attempts, availability, institutional decision, grounds, action and result, success criterion, every evidence question, observed or intended, alternative assessments, related entries, other identifiers, category mappings.

Cite this record

Peter H. Vartanian. (2026). uAI-CTA-HeadNeckVessels helped doctors find more brain aneurysms (AIBD-1064). Artificial Intelligence Benefits Database, edition of 1 November 2026. https://petervartanian.xyz/aibd/records/AIBD-1064.html (archived at https://doi.org/10.7910/DVN/AADSII, version 7.0)

BibTeX Data Field definitions